We are live on
!
Find out more
VAM
Visium Asset Management Portfolio holdings
AUM
$1.43B
1-Year Est. Return
3.58%
This Fund
S&P 500
This Quarter
Est. Return
+13.68%
1 Year Est. Return
-3.58%
3 Year Est. Return
+100.3%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$6.18B
AUM Growth
+$1.08B
(+21%)
Cap. Flow
+$404M
Cap. Flow
% of AUM
6.55%
Top 10 Holdings %
Top 10 Hldgs %
31.51%
Holding
1,163
New
297
Increased
261
Reduced
271
Closed
313
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ENDP
Endo International plc
ENDP
|
+$197M |
| 2 |
AGN
Allergan plc
AGN
|
+$135M |
| 3 |
Bausch Health
BHC
|
+$129M |
| 4 |
CVS Health
CVS
|
+$107M |
| 5 |
McKesson
MCK
|
+$94.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan Inc
AGN
|
+$286M |
| 2 |
ICPT
Intercept Pharmaceuticals, Inc.
ICPT
|
+$225M |
| 3 |
Gilead Sciences
GILD
|
+$86.1M |
| 4 |
Perrigo
PRGO
|
+$79.4M |
| 5 |
Cardinal Health
CAH
|
+$74.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 53.16% |
| 2 | Consumer Discretionary | 5.06% |
| 3 | Energy | 4.01% |
| 4 | Utilities | 3.23% |
| 5 | Financials | 3.21% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
VXRT
276
DELISTED
Vaxart
VXRT
| $3.67M | 0.06% |
+54,545
| New | +$3.37M |
|
277
Goodyear
GT
$2B
| $3.6M | 0.06% |
137,826
-148,219
| -52% | -$3.78M |
|
|
UPI
278
DELISTED
UROPLASTY INC-NEW
UPI
| $3.59M | 0.06% |
989,000
-90,400
| -8% | -$353K |
|
279
Iron Mountain
IRM
$36.4B
| $3.57M | 0.06% |
140,017
+79,468
| +131% | +$2.03M |
|
|
ALR
280
DELISTED
Alere Inc
ALR
| $3.55M | 0.06% |
103,286
-305,299
| -75% | -$11.2M |
|
281
Abbott
ABT
$183B
| $3.52M | 0.06% |
91,324
-1,764,143
| -95% | -$68M |
|
282
TSMC
TSM
$2.1T
| $3.51M | 0.06% |
175,387
-5,687
| -3% | -$102K |
|
|
NRF
283
DELISTED
NorthStar Realty Finance Corp.
NRF
| $3.49M | 0.06% |
109,964
-22,300
| -17% | -$656K |
|
|
BHI
284
DELISTED
Baker Hughes
BHI
| $3.48M | 0.06% |
+53,596
| New | +$3.17M |
|
|
WLL
285
DELISTED
Whiting Petroleum Corporation
WLL
| $3.44M | 0.06% |
165
+153
| +1,275% | +$2.9M |
|
|
LSI
286
DELISTED
LSI CORPORATION
LSI
| $3.41M | 0.06% |
307,521
+26,375
| +9% | +$291K |
|
287
Meta Platforms (Facebook)
META
$1.42T
| $3.39M | 0.05% |
56,250
-37,180
| -40% | -$2.36M |
|
|
OSG
288
Octave Specialty Group
OSG
$243M
| $3.35M | 0.05% |
+107,955
| New | +$2.98M |
|
|
LNKD
289
DELISTED
LinkedIn Corporation
LNKD
| $3.35M | 0.05% |
+18,098
| New | +$3.71M |
|
290
Boston Beer
SAM
$1.91B
| $3.34M | 0.05% |
+13,628
| New | +$3.11M |
|
|
CAM
291
DELISTED
CAMERON INTERNATIONAL CORPORATION
CAM
| $3.33M | 0.05% |
+53,868
| New | +$3.27M |
|
292
Honeywell
HON
$77B
| $3.31M | 0.05% |
39,672
+33,774
| +573% | +$2.8M |
|
|
FNFG
293
DELISTED
FIRST NIAGARA FINANCIAL GROUP INC
FNFG
| $3.26M | 0.05% |
344,586
+324,903
| +1,651% | +$3.01M |
|
|
MR
294
DELISTED
MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A
MR
| $3.25M | 0.05% |
+100,467
| New | +$3.52M |
|
295
AGCO
AGCO
$7.15B
| $3.23M | 0.05% |
58,516
+50,346
| +616% | +$2.69M |
|
|
BDBD
296
DELISTED
BOULDER BRANDS INC
BDBD
| $3.18M | 0.05% |
+180,520
| New | +$2.77M |
|
297
TIM SA
TIMB
$9.16B
| $3.17M | 0.05% |
122,132
+58,557
| +92% | +$1.52M |
|
|
IMRS
298
DELISTED
IMRIS INC COMMON SHARES (CANADA)
IMRS
| $3.15M | 0.05% |
2,009,360
+100,000
| +5% | +$201K |
|
299
Dick's Sporting Goods
DKS
$17.5B
| $3.1M | 0.05% |
56,781
+36,781
| +184% | +$1.99M |
|
|
ABMD
300
DELISTED
Abiomed Inc
ABMD
| $3.05M | 0.05% |
+117,279
| New | +$3.24M |
|
Similar funds
FBNAT
CPS
LH
CPM
VFS
ZA
FVFIGP
WA
Visium Asset Management's Q1 2014 Portfolio in Review
As of Q1 2014, Visium Asset Management held 1,163 positions worth $6.18B, up 21% from $5.09B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
Visium Asset Management deployed $404M of net new capital in Q1 2014, opening 297 new positions and adding to 261 existing holdings. Its largest new stake was Regeneron Pharmaceuticals: 286,563 shares worth $86M.
By sector, the portfolio is most concentrated in Healthcare at 53% of assets, down from 54% a quarter earlier, followed by Consumer Discretionary and Energy.
On the sell side, the largest reduction was Allergan Inc, an estimated $286M trimmed.
- Visium Asset Management's largest Q1 2014 buy was Regeneron Pharmaceuticals: 286,563 shares worth $86M.
- Visium Asset Management added most to Endo International plc in Q1 2014, an estimated $197M increase.
- Visium Asset Management's biggest Q1 2014 reduction was Allergan Inc, cutting an estimated $286M.
- Visium Asset Management fully exited Momenta Pharmaceuticals, Inc. in Q1 2014, selling an estimated $64M.
- Visium Asset Management's ten largest holdings make up 32% of its $6.18B portfolio in Q1 2014.
- Visium Asset Management opened 297 new positions and closed 313 in Q1 2014.
- Visium Asset Management's portfolio value rose 21% quarter-over-quarter to $6.18B.
Based on Visium Asset Management's 13F filing for Q1 2014, filed 15 May 2014.